Long acting β2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials
-
* Corresponding author: Don Husereau donh@ccohta.ca
- Equal contributors
BMC Pulmonary Medicine 2004, 4:7 doi:10.1186/1471-2466-4-7
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 16 Sep 2003 | |
| Reviewer's Report | Mario Cazzola | 05 Oct 2003 | |
| Reviewer's Report | Piersante Sestini | 06 Oct 2003 | |
| Reviewer's Report | Elmer Villanueva | 18 Nov 2003 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 27 Feb 2004 |
| Reviewer's Report | Piersante Sestini | 31 Mar 2004 | |
| Published | 31 Aug 2004 |